Hanseatic Management Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-3,921
Closed -$601K 100
2022
Q2
$601K Buy
3,921
+105
+3% +$16K 1.37% 18
2022
Q1
$619K Buy
+3,816
New +$554K 1.07% 26
2020
Q4
Sell
-884
Closed -$77K 152
2020
Q3
$77K Buy
+884
New +$83.2K 0.17% 106
2018
Q2
Sell
-8,090
Closed -$766K 386
2018
Q1
$766K Buy
8,090
+1,198
+17% +$132K 0.73% 42
2017
Q4
$667K Buy
6,892
+6,300
+1,064% +$594K 0.67% 56
2017
Q3
$53K Buy
+592
New +$45.1K 0.06% 144
2015
Q1
Sell
-45,149
Closed -$2.96M 304
2014
Q4
$2.96M Buy
+45,149
New +$2.85M 1.52% 8
2014
Q1
Sell
-29,170
Closed -$1.54M 234
2013
Q4
$1.54M Buy
+29,170
New +$1.43M 0.98% 26
2013
Q3
Sell
-11,740
Closed -$485K 239
2013
Q2
$485K Buy
+11,740
New +$513K 0.29% 84

Other funds holding ABBV

Hanseatic Management Services's ABBV Position: Q3 2022 in Review

Hanseatic Management Services sold out of AbbVie (ABBV) in Q3 2022, closing a stake of 3,921 shares — an estimated $601K sold.

Hanseatic Management Services first reported a position in ABBV in Q2 2013 and held it in 9 quarters. The position peaked at $2.96M in Q4 2014. 2,969 funds tracked by Wall St. Rank hold ABBV as of Q3 2022.

  • Hanseatic Management Services reported no remaining AbbVie position as of Q3 2022 after selling out during the quarter.
  • Hanseatic Management Services sold 3,921 AbbVie shares in Q3 2022, an estimated $601K.
  • Hanseatic Management Services first reported a position in AbbVie in Q2 2013 and held it in 9 quarters.
  • Hanseatic Management Services's AbbVie position peaked at $2.96M in Q4 2014.
  • 2,969 funds tracked by Wall St. Rank held AbbVie as of Q3 2022.

Based on Hanseatic Management Services's 13F filing for Q3 2022, filed 8 Nov 2022.